Scrip’s Five Must-Know Things – 3 October 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: major Q4 catalysts; Verona’s COPD contender; Alfasigma acquires Intercept; more setbacks for Keytruda/Lenvima combo; and new pressures on China IPOs. https://scrip.citeline.com/SC149131/Quick-Listen-Scrips-Five-MustKnow-Things